Journal Of Clinical Oncology (jco) Podcast

Adjuvant Trastuzumab Passes the Test of Time

Informações:

Synopsis

Long-term follow up from the landmark, NCI-sponsored adjuvant trastuzumab trials confirms the clinical benefits and clinical safety of this important therapy.